In addition to these innovations, as part of studies to optimize the beacons, researchers have learned how molecular beacon design and other factors affect binding time, specificity and accuracy.

A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2’s spike protein receptor-binding domain (S-RBD) using computationally validated peptide ...